Olmetec and Eliquis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Olmetec (olmesartan medoxomil) and Eliquis (apixaban). Common drug interactions include cough among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Olmetec and Eliquis. It is created by eHealthMe based on reports of 189 people who take the same drugs from the FDA, and is updated regularly.
What is Olmetec?
Olmetec has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 7,904 Olmetec users. Check the latest studies of Olmetec.
What is Eliquis?
Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
189 people who take Olmetec and Eliquis together, and have interactions are studied.
What are the common drug interactions of Olmetec and Eliquis, by gender? *
What are the common drug interactions of Olmetec and Eliquis, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Olmetec and Eliquis?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Olmetec and Eliquis:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olmetec:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Eliquis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olmetec and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Eliquis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olmesartan medoxomil and apixaban (the active ingredients of Olmetec and Eliquis, respectively), and Olmetec and Eliquis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Roxicodone vs. Feldene, side effect and effectiveness comparison - 17 seconds ago
- Drug interactions of Tazidime and Ursodeoxycholic Acid - 23 seconds ago
- Glipizide and Simvastatin drug interactions for women aged 40-49 - 25 seconds ago
- Fish Oil and Tylenol drug interactions for women aged 30-39 - 38 seconds ago
- Drug interactions of Lupron and Cipro - 42 seconds ago
- Could Haloperidol cause Self-Injurious Ideation? - 59 seconds ago
- Ramipril and Coronary Artery Stenosis for Women aged 60+ - a minute ago
- Folic Acid and Benicar drug interactions for men aged 50-59 - a minute ago
- Myrbetriq and Weakness for Men aged 20-29 - a minute ago
- Myrbetriq and Asthenia for Men aged 20-29 - a minute ago